Ductal Carcinoma In Situ Active Monitoring Trials: Do Eligibility Criteria Identify Patients at Low Risk for Upgrade to Invasive Carcinoma?
More precise criteria and predictive biomarkers are needed to better stratify DCIS lesions and exclude women harboring invasive carcinomas from AM regimens.
Authors
- Elaheh Sobhani (ORCID: https://orcid.org/0000-0002-4532-7168)
- Marilyn M. Bui (ORCID: https://orcid.org/0000-0003-4963-2255)
- Olya Stringfield
- Natarajan Raghunand (ORCID: https://orcid.org/0000-0002-8893-7687)
- Mahmoud A. Abdalah (ORCID: https://orcid.org/0000-0002-0573-4121)
- Issam El Naqa
- B. Niell
- D. Ataya
- K Ruwani M Fernando
- Yarelis De La Cruz (ORCID: https://orcid.org/0009-0009-7087-6546)
- Jasmine Brainerd
Institutions
- Moffitt Cancer Center (US)
Publication Details
- Journal
- Journal of Breast Imaging
- Published
- 2026-01-29
- DOI
- https://doi.org/10.1093/jbi/wbaf085
- Primary Topic
- Breast Cancer Treatment Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00